Drug Approval | March 10, 2023
Zydus receives final approval from the USFDA for Erythromycin Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose
Evidence also shows better immune response to virus among users of spray
The company to receive upfront and milestone payments, in addition to royalties
TAH is now undergoing regulatory clearance and final quality control procedures for the swab deployment in India, EU, Singapore, UK, US, Australia and others for COVID-19 testing
Subscribe To Our Newsletter & Stay Updated
